Patents Examined by Gina C Justice
  • Equine dietary supplement
    Patent number: 11033492
    Abstract: An equine dietary supplement which is fed to a horse to improve the health of the horse includes a mixture containing chia seeds, whey dextrose and bee pollen.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: June 15, 2021
    Inventor: Mary Hartman
  • Formulation of a micro drop pill and the preparation method thereof
    Patent number: 11013694
    Abstract: The present invention relates to a preparation method for a traditional Chinese medicine drop pill and a traditional Chinese medicine micro drop pill prepared by using the method, and in particular, the present invention relates to a micro drop pill preparation method with high drug-loading capacity, simple preparation process and high production rate and a micro drop pill prepared by using the method. Specially, The drop pill preparation method used comprises the following steps: (1) material melting step: heat melting a medicine and a drop pill matrix to obtain a molten medicine liquid; (2) dropping step: delivering the molten medicine liquid to a dripper, and acquiring medicine drops of the molten medicine liquid by means of vibration dropping; and, (3) condensation step: cooling the medicine drops with a cooling gas to obtain micro drop pills.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: May 25, 2021
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xijun Yan, Naifeng Wu, Kaijing Yan, Xiaobing Sun, Shunnan Zhang, Zhengliang Ye, Hai'ou Dong, Hongbo Zhang, Wensheng Zhang, Lihong Zhou, Chenming Li, Cong Chen, Xiaofeng Liu, Shiqing Wang, Changsheng Rong, Yongfeng Zheng, Lijun Fan
  • Compositions and methods for treating non-cornified epithelial tissue of a female body
    Patent number: 11000592
    Abstract: Compositions for treating non-cornified epithelial tissue of a female body, such as the labia, introitus, and the vagina are disclosed. Methods of regulating dryness in these tissues are also disclosed.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: May 11, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Paul Robert Tanner, Larry Richard Robinson
  • Insect repellent formulation for surface protection
    Patent number: 11000040
    Abstract: The composition of a set of formulations based on synthetic active ingredients and natural boosting additives, which provide repellent action against flying insects such as mosquitoes, flies and black-winged stilts, as well as crawling insects such as cockroaches and ants.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: May 11, 2021
    Assignee: IPEL-ITIBANYL PRODUTOS ESPECIAIS LTDA
    Inventors: Walter Piccirillo Pinto, Giovanni Caritá Júnior
  • Antibacterial dressing material and preparing method therefor
    Patent number: 10987447
    Abstract: The present invention relates to an antibacterial dressing and a method for preparing the same. According to the present invention, there are provided an antibacterial dressing containing a rapid cell membrane-penetrating component that exhibits excellent bactericidal and antibacterial activities by disrupting the structure and synthesis of protein and nucleic acid, and a method for preparing the same.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: April 27, 2021
    Assignee: Genewel Co., Ltd.
    Inventors: Hyun Jung Kim, Il Kyu Park, Seung Moon Lee, Yong Soo Kim
  • Tablet capable of combatting misuse by injection
    Patent number: 10987309
    Abstract: The invention relates to an oral pharmaceutical composition in the form of a sustained-release tablet comprising an active ingredient capable of being misused, which composition makes it possible to combat misuse by injection.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: April 27, 2021
    Assignee: ETHYPHARM
    Inventors: Catherine Herry, Pauline Contamin
  • Low-substituted hydroxypropyl cellulose and solid preparation
    Patent number: 10959959
    Abstract: Provided is low-substituted hydroxypropyl cellulose from which a granulation product having an adequate particle size can be obtained in a wet granulation method and a tablet having excellent compactibility and disintegrability can be obtained. More specifically, provided is low-substituted hydroxypropyl cellulose having a hydroxypropoxyl content of from 5 to 16% by weight and a water-soluble content of less than 2% by weight, wherein a weight ratio of water to the low-substituted hydroxypropyl cellulose giving a maximum torque is from 3 to 5 as determined while adding one part by weight of water per minute to one part by weight of the low-substituted hydroxypropyl cellulose under mixing with biaxial mixing blades. Also provided are a solid preparation including the low-substituted hydroxypropyl cellulose, and the like.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: March 30, 2021
    Assignee: SHIN-ETSU CHEMICAL CO., LTD.
    Inventors: Yasuyuki Hirama, Naosuke Maruyama
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 10940115
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: March 9, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Delayed release deferiprone tablets and methods of using the same
    Patent number: 10940116
    Abstract: The invention is directed to pharmaceutical compositions such as tablets that exhibit delayed release properties when administered as either whole or half tablets. The invention is also directed to delayed release tablets comprising deferiprone for oral administration, for which twice daily administration is bioequivalent to the same daily dose of an immediate release tablet administered thrice daily. The invention is also directed to methods of making and using the same.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: March 9, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Bernard Charles Sherman, Michael Spino
  • Compositions for the treatment of dermatological diseases and disorders
    Patent number: 10918652
    Abstract: The present disclosure is directed to topical dermatological formulations, dermatological cleansing compositions, and bathwater conditioners designed to acidify the skin, and their use for restoring epidermal acidity, restoring a the epidermal barrier, inhibiting inflammation, establishing an environment appropriate for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: February 16, 2021
    Assignee: Claridei Laboratories, Inc.
    Inventor: Cheryl Lee Eberting
  • Compositions and methods for the treatment of bacterial vaginosis
    Patent number: 10918663
    Abstract: Described herein are methods and formulations for treating, inhibiting, or ameliorating vaginitis, including bacterial vaginosis. Aspects described herein relate to formulations including a reactive oxygen species, a rheology agent, and a silicone polymer and methods of using these formulations for treating, ameliorating, or inhibiting a vaginitis, including bacterial vaginosis.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: February 16, 2021
    Assignee: REOXCYN, LLC
    Inventors: Kurt Richards, Jeffrey Mocny
  • Personal care compositions containing complexing polyelectrolytes
    Patent number: 10912730
    Abstract: Compositions of the invention contain, in a cosmetically acceptable aqueous medium, a) a cationic polyelectrolyte, b) at least one surfactant; and (c) from about 0.01 to about 1.2 weight percent of an anionic polyelectrolyte, where the weight ratio of the anionic polyelectrolyte to the cationic polyelectrolyte is from about 0.05 to about 1.2, and where the composition exhibits a viscosity change that is below a minimum significant-change-threshold (??min) and exhibits no measurable yield stress or increase in yield stress value when compared to a substantially identical composition that does not contain from about 0.01 to about 1.2 weight percent of the anionic polyelectrolyte, at a weight ratio of anionic polyelectrolyte to cationic polyelectrolyte of from about 0.05 to about 1.2.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: February 9, 2021
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Michael J. Fevola, Tobias J. Fuetterer, Matthew A. Lohr
  • Methods and materials for reducing the risk of infections
    Patent number: 10835547
    Abstract: This document relates to methods and materials for reducing the risk of infection after a shoulder surgery or medical procedure. For example, this document relates to methods and materials for using a topical composition containing clindamycin or erythromycin to reduce the risk of or to prevent infection associated with shoulder surgeries or medical procedures.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: November 17, 2020
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: John W. Sperling, Adam A. Sassoon
  • Treatment of hepatitis delta virus infection
    Patent number: 10828283
    Abstract: Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: November 10, 2020
    Assignee: Eiger Biopharmaceuticals, Inc.
    Inventors: David A. Cory, Ingrid Choong, Jeffrey S. Glenn
  • In situ gelling formulation for reduced initial drug burst
    Patent number: 10813882
    Abstract: An in situ gel formulation comprising poly lactide-co-?-caprolactone (PLCL), a surfactant with a hydrophilic-lipophilic balance value of 14-15, a plasticizer, and a statin is provided. Methods of treating hyperlipidemia by parenterally administering the in situ gel formulation are also provided.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: October 27, 2020
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Tarek A. Ahmed, Mohammed M. Mussari, Abdelsattar M. Omar, Khalid M. El-Say
  • Cosmetic product
    Patent number: 10806682
    Abstract: A cosmetic product includes a container main body that has an opening at one end thereof and contains a cosmetic therein, and a lid that has an application tool provided with an application element at a tip portion thereof and inserted into the opening part. When the lid is attached to the container main body, the application element and the cosmetic are brought into contact with each other and the cosmetic is hermetically sealed. The cosmetic contains (A) wax which is solid at 25° C., (B) powder, (C) film-forming agent, and (D) volatile oil agent, and a content of the (C) film-forming agent is 10% to 40% by mass based on a total amount of the cosmetic.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: October 20, 2020
    Inventor: Hidekazu Yano
  • Bi-layer dual release probiotic tablets
    Patent number: 10799541
    Abstract: The present invention generally relates to dietary supplement and pharmaceutical formulations comprising layered acid protective oral dosage formulations comprising probiotics and provided as single unified or cohesive dosage form units. Each individual acid protective layer of the cohesive dosage form provides one of a different probiotic payload, a different release profile to target delivery of probiotic to a particular region in the gastrointestinal tract, or both different probiotic payloads and release profiles to target delivery of different probiotics to particular regions in the gastrointestinal tract.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: October 13, 2020
    Assignee: PROBI USA, INC.
    Inventors: Timothy Gamble, Anthony Blanch
  • Methods, compositions and uses relating thereto
    Patent number: 10799440
    Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising a hydroxy-substituted aldehyde.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: October 13, 2020
    Assignee: Innospec Limited
    Inventors: Tony Gough, Matthew Robert Giles, Kimberley Elizabeth Griffiths, Nicholas John Dixon, Ian Malcolm McRobbie
  • Protein kinase C inhibitors and uses thereof
    Patent number: 10792282
    Abstract: This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: October 6, 2020
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Rajinder Singh, Matthew Duncton, Jing Zhang, Salvador Alvarez, Kin Tso, Sacha Holland, Rose Yen, Rao Kolluri, Thilo Heckrodt, Yan Chen, Esteban Masuda, Hui Li, Donald G. Payan
  • Polyacrylamide hydrogel for use in the prevention and/or treatment of synovitis in a mammal
    Patent number: 10772991
    Abstract: The present invention relates to a polyacrylamide hydrogel for use in prevention and/or treatment of synovitis or pain associated with synovitis in a mammal by formation of an extra layer to the synovial membrane i.e. a sub-synovial layer and a novel synovial lining layer. Synovitis may occur in association with arthritis, such as osteoarthritis or rheumatoid arthritis, lupus, or gout, and the mammal suffering from synovitis is a preferably a human, a racing animal or a companion animal.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: September 15, 2020
    Assignee: Contura International A/S
    Inventors: Ieva Ankorina-Stark, Lise Hanne Christensen